IN2014MN02582A - - Google Patents

Info

Publication number
IN2014MN02582A
IN2014MN02582A IN2582MUN2014A IN2014MN02582A IN 2014MN02582 A IN2014MN02582 A IN 2014MN02582A IN 2582MUN2014 A IN2582MUN2014 A IN 2582MUN2014A IN 2014MN02582 A IN2014MN02582 A IN 2014MN02582A
Authority
IN
India
Prior art keywords
compound
formula
present
discloses
preparing
Prior art date
Application number
Other languages
English (en)
Inventor
Dharmaraj Ramachandra Rao
Rajendra Narayanrao Kankan
Srinivas Laxminarayan Pathi
Ravikumar Puppala
Manish Gangrade
Shashirekha Kanathala
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to IN2582MUN2014 priority Critical patent/IN2014MN02582A/en
Publication of IN2014MN02582A publication Critical patent/IN2014MN02582A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/022—Boron compounds without C-boron linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IN2582MUN2014 2006-11-13 2007-11-13 IN2014MN02582A (cs)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2582MUN2014 IN2014MN02582A (cs) 2006-11-13 2007-11-13

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1879MU2006 2006-11-13
IN2582MUN2014 IN2014MN02582A (cs) 2006-11-13 2007-11-13
PCT/GB2007/004320 WO2008059223A2 (en) 2006-11-13 2007-11-13 Process for the synthesis of moxifloxacin hydrochloride

Publications (1)

Publication Number Publication Date
IN2014MN02582A true IN2014MN02582A (cs) 2015-09-11

Family

ID=38947366

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2582MUN2014 IN2014MN02582A (cs) 2006-11-13 2007-11-13

Country Status (10)

Country Link
US (1) US8198451B2 (cs)
EP (2) EP2474547A3 (cs)
JP (2) JP2010509305A (cs)
KR (2) KR101539561B1 (cs)
AU (1) AU2007320997B2 (cs)
CA (1) CA2669427A1 (cs)
IN (1) IN2014MN02582A (cs)
NZ (1) NZ576929A (cs)
WO (1) WO2008059223A2 (cs)
ZA (1) ZA200903889B (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010509305A (ja) 2006-11-13 2010-03-25 シプラ・リミテッド モキシフロキサシン塩酸塩の合成方法
CN101817820B (zh) * 2009-07-30 2011-10-05 重庆博腾制药科技股份有限公司 一种盐酸莫西沙星的合成方法
WO2011121596A2 (en) * 2010-04-01 2011-10-06 Neuland Laboratories Ltd. Crystal modification of moxifloxacin hydrochloride
CN102309458B (zh) * 2010-07-09 2016-02-03 北京圣医耀科技发展有限责任公司 海藻酸钠交联莫西沙星缓释微球、其制备方法和用途以及含有所述微球的血管靶向栓塞剂
CN102617622B (zh) * 2011-01-31 2016-06-15 深圳信立泰药业股份有限公司 一种制备莫西沙星或其可药用盐及其中间体的方法
CN102276603B (zh) * 2011-07-14 2012-10-24 福建省福抗药业股份有限公司 一种盐酸莫西沙星的清洁制备方法
ITTO20110705A1 (it) 2011-07-29 2013-01-30 Italiana Sint Spa Procedimento di preparazione della moxifloxacina cloridrato e relativi intermedi
CN102659761B (zh) * 2012-04-27 2017-10-10 常州市亚邦医药研究所有限公司 盐酸贝西沙星的制备方法
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CA2893534A1 (en) 2012-12-04 2014-06-12 Mankind Research Centre An improved process for the preparation of moxifloxacin hydrochloride
CN103102341A (zh) * 2012-12-14 2013-05-15 浙江普洛康裕制药有限公司 一种巴洛沙星二水合物的制备方法
CN103012452B (zh) * 2012-12-25 2015-12-02 浙江新和成股份有限公司 一种莫西沙星及其盐酸盐的制备方法
CN104098561B (zh) * 2013-04-10 2016-01-20 山东省生物医药科学院 一种适合工业化生产的制备高光学纯度盐酸莫西沙星的方法
CN104031043B (zh) * 2014-05-28 2016-03-16 成都克莱蒙医药科技有限公司 一种盐酸莫西沙星合成方法
CN104860944A (zh) * 2015-06-09 2015-08-26 内蒙古东北六药集团有限公司 盐酸莫西沙星的生产方法
CN105237535A (zh) * 2015-11-15 2016-01-13 青岛麦瑞特医药技术有限公司 一种制备盐酸莫西沙星的方法
CN105669671A (zh) * 2016-03-10 2016-06-15 陈红 一种盐酸莫西沙星的制备方法
CN110143959B (zh) * 2019-05-10 2022-04-26 广西两面针亿康药业股份有限公司 一种盐酸莫西沙星的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU46451B (sh) * 1987-04-08 1993-10-20 Chinoin Gyogyszer Es Vegyeszeti Ter Mekek Gyara Rt. Postupak za dobivanje mešovitih anhidrida hinolin-karboksilne i borne kiseline
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
JPH0778065B2 (ja) 1990-07-06 1995-08-23 杏林製薬株式会社 （６，７―置換―８―アルコキシ―１―シクロプロピル―１，４―ジヒドロ―４―オキソ―３―キノリンカルボン酸―ｏ▲上３▼，ｏ▲上４▼）ビス（アシルオキシ―ｏ）ホウ素化合物及びその塩並びにその製造方法
TW209865B (cs) 1992-01-10 1993-07-21 Bayer Ag
ES2077490B1 (es) * 1992-11-18 1996-10-16 Marga Investigacion Esteres trimetilsililicos y solvatos de quelatos de acidos quinolin-3-carboxilicos. preparacion y aplicacion al proceso de quinolonas.
DE4342186A1 (de) 1993-12-10 1995-06-14 Bayer Ag Eintopfverfahren zur Herstellung von 3-Chinoloncarbonsäurederivaten
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE19821039A1 (de) * 1998-05-11 1999-11-18 Bayer Ag Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan
US6174878B1 (en) * 1999-08-31 2001-01-16 Alcon Laboratories, Inc. Topical use of kappa opioid agonists to treat otic pain
CN1184221C (zh) * 2001-08-08 2005-01-12 中国医学科学院医药生物技术研究所 有7－(7－氨甲基－5－氮杂螺[2,4]庚烷)取代基的新喹啉羧酸衍生物及其制备方法
CA2521398C (en) * 2003-04-09 2011-03-22 Dr. Reddy's Laboratories Limited A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for preparation thereof
US20060264635A1 (en) * 2003-08-05 2006-11-23 Chava Satyanarayana Process for the preparation of moxifloxacin hydrochloride
ES2319125T3 (es) * 2003-11-20 2009-05-04 Chemi S.P.A. Polimorfos del clorhidrato del acido 1-ciclopropil-7-((s,s)-2,8-diazadiciclo(4.3.0)-non-8-il)-6-fluoro-1,4-dihidro-8-metoxi-4-oxo-3-quinolina carboxilico y metodos para la preparacion de los mismos.
US7320006B2 (en) * 2004-11-12 2008-01-15 Computer Sciences Corporation Hierarchical database management
WO2006134491A2 (en) * 2005-06-14 2006-12-21 Aurobindo Pharma Limited New crystalline form of moxifloxacin hydrochloride and process for its preparation
WO2007010555A2 (en) 2005-07-15 2007-01-25 Msn Laboratories Limited Novel crystalline forms of moxifloxacin hydrochloride and process for preparation thereof
ES2284380B1 (es) 2006-03-10 2008-11-01 Quimica Sintetica S.A. Procedimiento para la preparacion de moxifloxacino y moxifloxacino clorhidrato.
JP2010509305A (ja) 2006-11-13 2010-03-25 シプラ・リミテッド モキシフロキサシン塩酸塩の合成方法

Also Published As

Publication number Publication date
JP5774732B2 (ja) 2015-09-09
US20100152229A1 (en) 2010-06-17
KR20150048920A (ko) 2015-05-07
JP2014122223A (ja) 2014-07-03
CA2669427A1 (en) 2008-05-22
WO2008059223A2 (en) 2008-05-22
JP2010509305A (ja) 2010-03-25
AU2007320997A1 (en) 2008-05-22
KR101539561B1 (ko) 2015-07-27
ZA200903889B (en) 2010-03-31
EP2089388A2 (en) 2009-08-19
KR20090090337A (ko) 2009-08-25
NZ576929A (en) 2012-07-27
AU2007320997B2 (en) 2012-11-08
EP2474547A2 (en) 2012-07-11
WO2008059223A3 (en) 2008-07-31
EP2089388B1 (en) 2014-01-29
EP2474547A3 (en) 2012-07-25
US8198451B2 (en) 2012-06-12

Similar Documents

Publication Publication Date Title
IN2014MN02582A (cs)
MX2011005936A (es) Compuestos organicos.
TW200613515A (en) Compounds for organic electronic devices
EA201170524A1 (ru) Урацилсодержащие соединения и гербициды, включающие такие соединения
TN2011000247A1 (en) Organic compounds
WO2008101187A3 (en) Pro-drugs of peripheral phenolic opioid antagonists
TW200738648A (en) New imidazole derivatives, preparation method thereof and organic electronic device using the same
ES2531324T3 (es) Intermedio para producir un derivado de gamma-aminoácido bicíclico
ATE504554T1 (de) Verfahren zur substitution von indenofluorenen
GEP20135780B (en) Novel pyrazolo [3,4-d] pyrimidine derivatives as anti-cancer agents
WO2011038185A3 (en) Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
DK1877384T3 (da) Fremgangsmåde til fremstilling af eventuelt 2-substituerede 1,6-dihydro-6-oxo-4-pyrimidincarboxylsyrer
DE602006003320D1 (de) Herstellung eines substituierten chinoxalins von hoher reinheit
WO2008083950A8 (de) Spirocyclische tetronsäure-derivative
WO2009066735A1 (ja) ２－アザアダマンタン類の製造方法
MX2009004991A (es) Derivados de monoacetato de ciclopenteno-diol.
WO2010120058A2 (ko) 생체 분자 표지를 위한 신규 시아닌 화합물 및 그 제조방법
WO2009001203A3 (en) An improved process for the preparation of aprepitant
NZ593763A (en) Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
WO2009139002A3 (en) An improved process for the preparation of solifenacin and its pharmaceutically acceptable salts thereof
WO2009125425A3 (en) Improved process for the preparation of (s.s)-2.8-diazabicyclo[4.3.0]nonane
UA99455C2 (ru) Эпоксидное соединение, способ его получения и способ получения соединения оксазола
DE602006014001D1 (de) Herstellung von 2-aminothiazol-5-carbonsäurederivaten
BRPI0513712A (pt) método para a preparação de derivado de d-eritro-2,2-difluoro-2-desóxi-1-oxorribose
TW200619213A (en) A process for the preparation of organic compounds